Form D — Avery Therapeutics, Inc.
0001708135-26-000003 · filed Sep 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $15,400,000
- Reported amount sold
- $8,468,859
- Minimum investment
- $0
- Investors
- 23
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Avery Therapeutics, Inc.
- CIK
- 1708135
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2500 N. TUCSON BLVD. STE. 140
TUCSON, AZ 85716 - Phone
- 520-977-4980
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jordan Lancaster · Executive OfficerTucson, AZ Find on LinkedIn ↗
-
Lawrence Mehren · DirectorTucson, AZ Find on LinkedIn ↗
-
Emile Nuwaysir · DirectorTucson, AZ Find on LinkedIn ↗
-
Steven Goldman · Executive OfficerTucson, AZ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗